No takes yet. Share an insight, caveat, or question.
New vaccines represent an exciting development in the global response to the emergence of EV71 as a cause of severe neurologic disease.
Peter C. McMinn (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: